Table 1.
Participant characteristics
|
Characteristic |
Group 1: Discriminant analysis |
Group 2: Responsiveness |
|---|---|---|
| N = 38 | N = 44 | |
| Age M (SD) |
56.11 (12.4) |
60.4 (13.2) |
| Gender (% female) |
77 |
73 |
| Dominant Symptom* |
Cough 19 (54%) |
Cough 38 (86%) |
| Breathing 8 (23%) |
Breathing 4 (9%) |
|
| |
Globus/swallow 2 (5%) |
|
| Globus/swallow 5 (14%) |
|
|
| Smoking |
Yes 4 (11%) |
No 44 (100%) |
| No 28 (80%) |
|
|
| Passive 3 (9%) |
|
|
| Associated medical conditions/previous medical history** |
Reflux: 17 (49%); Asthma:10 (29%); Rhinitis: 6 (17%); History of psychiatric disorder: 5 (14%); Obstructive Sleep Apnoea: 4 (11%); unrelated comorbidities: 13 (34%). |
Reflux: 9 (21%); Asthma: 12 (27%); Rhinitis: 12 (27%); History of psychiatric disorder: 9 (21%); Bronchiectasis: 1 (2%); unrelated comorbidities: 5 (11) |
| Other treatment | Asthma treatment (inhaled bronchodilators or inhaled corticosteroids): 17 (49%); Proton pump inhibitor: 19 (54%); Antihistamines: (3%); Nasal/sinus treatment: 5 (14%); Antibiotics: (11%); Continuous Positive Airway Pressure: 1 (3%); Lifestyle changes for reflux: 1 (3%). | Asthma treatment 12 (27%); Proton pump inhibitor 12 (27%); antihistamines 12 (27%) |
Note. *Three patients had mixed symptoms. **All associated medical conditions had been treated.